awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4
Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
P2860
Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7008aabf6f65a0fa019615e5eaffd975091c574c
P2860
Tissue inhibitor of metalloproteinases-1 in breast cancer.